Attached files
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Innovus Pharmaceuticals,
Inc. (the “Company”) on Form 10-K for the year ended
December 31, 2017, as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, Bassam
Damaj, President and Chief Executive Officer of the Company, hereby
certifies, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to
SS. 906 of the Sarbanes-Oxley Act of 2002, that to his
knowledge:
1.
The
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended,
and
2.
The
information contained in the Report fairly presents, in all
material respects, the financial conditions and results of
operations of the Company.
Date: April 2, 2018
|
/s/ Bassam Damaj
|
|
Bassam Damaj, Ph.D.
|
|
President and Chief Executive Officer
|
|
(Principal Executive Officer)
|